Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Multiple Myeloma 25Leukemia, Myeloid, Acute 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Lymphoma 21Burkitt Lymphoma 19Myelodysplastic Syndromes 18Leukemia 17Lymphoma, Non-Hodgkin 15Lymphoma, Follicular 15Lymphoma, Large B-Cell, Diffuse 14Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Mantle-Cell 12Lymphoma, B-Cell, Marginal Zone 12Neoplasms, Plasma Cell 11Lymphoma, Large-Cell, Immunoblastic 11Hodgkin Disease 11Breast Neoplasms 11Recurrence 10Congenital Abnormalities 9Sarcoma 8Myeloproliferative Disorders 8Dendritic Cell Sarcoma, Interdigitating 8Leukemia, Myelomonocytic, Juvenile 7Leukemia, Myeloid, Chronic-Phase 7Lymphoma, T-Cell, Cutaneous 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Central Nervous System Neoplasms 6Sezary Syndrome 5

Interventions

lutetium Lu 177 dotatate 1lanreotide 1folfirinox 1famitinib 1Octreotide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cytokines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Gastro-enteropancreatic neuroendocrine tumor × Filgrastim × Clear all
NCT03042780 2020-11-27

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
2 enrolled 6 charts
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neoplasm Metastasis, Pancreatic Neoplasms, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡